A New MI-Based Visualization Aided Validation Index for Mining Big Longitudinal Web Trial Data by Zhang, Zhaoyang et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Population and Quantitative Health Sciences 
Publications Population and Quantitative Health Sciences 
2016-05-16 
A New MI-Based Visualization Aided Validation Index for Mining 
Big Longitudinal Web Trial Data 
Zhaoyang Zhang 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/qhs_pp 
 Part of the Biostatistics Commons, Epidemiology Commons, and the Health Services Research 
Commons 
Repository Citation 
Zhang Z, Fang H(, Wang H. (2016). A New MI-Based Visualization Aided Validation Index for Mining Big 
Longitudinal Web Trial Data. Population and Quantitative Health Sciences Publications. https://doi.org/
10.1109/ACCESS.2016.2569074. 
. Retrieved from https://escholarship.umassmed.edu/qhs_pp/1160 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Population and 
Quantitative Health Sciences Publications by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
A New MI-Based Visualization Aided Validation Index for Mining
Big Longitudinal Web Trial Data
Zhaoyang Zhang1, Hua Fang1, and Honggang Wang2
1Department of Quantitative Health Science, University of Massachusetts Medical School,
Worcester, MA 01605, USA
2Department of Electrical and Computer Engineering, University of Massachusetts Dartmouth,
North Dartmouth, MA 02747, USA
Abstract
Web-delivered clinical trials generate big complex data. To help untangle the heterogeneity of
treatment effects, unsupervised learning methods have been widely applied. However, identifying
valid patterns is a priority but challenging issue for these methods. This paper, built upon our
previous research on multiple imputation (MI)-based fuzzy clustering and validation, proposes a
new MI-based Visualization-aided validation index (MIVOOS) to determine the optimal number
of clusters for big incomplete longitudinal Web-trial data with inflated zeros. Different from a
recently developed fuzzy clustering validation index, MIVOOS uses a more suitable overlap and
separation measures for Web-trial data but does not depend on the choice of fuzzifiers as the
widely used Xie and Beni (XB) index. Through optimizing the view angles of 3-D projections
using Sammon mapping, the optimal 2-D projection-guided MIVOOS is obtained to better
visualize and verify the patterns in conjunction with trajectory patterns. Compared with XB and
VOS, our newly proposed MIVOOS shows its robustness in validating big Web-trial data under
different missing data mechanisms using real and simulated Web-trial data.
INDEX TERMS
Multiple imputation; clustering validation; pattern recognition; visualization; longitudinal web
trial data
 I. INTRODUCTION
The big data have been massively generated from web-delivered clinical trials [1]–[4].
These complex data provide valuable information for disentangling the heterogeneity of
treatment effect (HTE). HTE refers to the fact that patients exposed to a common influence
(such as tobacco exposure or randomization to a treatment) often experience very different
outcomes [5]–[7]. HTE is common in translational research, especially in complex, multi-
component interventions, such as Phase III trials designed to move evidence-based
guidelines into practice. Even in a randomized controlled trial (RCT), outcomes differ
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among patients within treated and control groups. Methods that can extract the full
information implicit in HTE hold great promise for delivering patient-centered care [8]–
[12].
In 2011, the NIH Comparative Effectiveness Research Key Function Committee and
Patient-Centered Outcome Research Institute (PCORI) specifically called for methods to
address HTE for improving the design, conduct, and analyses of patient-oriented research
[13]. A “holistic” approach to HTE considers the full domain of HTE demographics, pre-
treatment risks (e.g., psychological, physiological, genotype, environmental), experience of
side effects, differential responses to treatment, and health utility preferences as well as its
relationship with outcomes. Implementing such an approach has been described as “the next
great task of clinical research in the 21st century” [14].
Standard approaches to HTE use either a simple “exposed” or “non-exposed” grouping to
describe a complex treatment procedure for detecting binary effects (yes/no), or subgroups
based on arbitrarily determined cut-scores (e.g., quintiles or percentages), generating
possibly spurious false-positive findings [15]. Going beyond standard approaches,
unsupervised learning methods have been applied to HTE studies. Among them, our MI-
Fuzzy model has been developed [12], [16]–[20]. It uses all collected big trial data and
actual values of patients’ responses to characterize variations and changes in treatment over
time. This method can reduce the uncertainty of imputation and the uncertainty of the
clustering accuracy compared to non- or single-imputed methods commonly used in
unsupervised learning [17] and generate salient patterns from real-world data that are
longitudinal, non-normal, high dimensional and contain missing values. These salient
patterns represent different treatment “doses” patients received, which increase the
predictive power and facilitate detecting “gradient effects,” that is, varying degrees of
patients’ responses to treatment (“treatment uptake”) will lead to differences in outcomes
(e.g., severe, normal, mild).
However, in this line of research, a key problem is to determine the number of patterns or
clusters in these big complex data. Under the framework of fuzzy clustering, Xie & Beni
(XB) index is widely used, but its performance depends on the choice of the fuzzifiers,
therefore sensitive to some data types [21], [22]. Another recently developed overlap and
separation index (VOS) [23] is also designed for fuzzy clustering and independent of the
choice of fuzzifiers. However, it has the worst performance for the longitudinal web trial
data where the inflated zeros and missing values are common as shown in our numerical
analyses in this paper. Additionally, no matter how robust a validation index is, it might not
perform well for all data types. Since comparing different indexes may not always result in
consistent findings based on our empirical research, visualization may help verify, tease out
trivial clusters and determine the optimal number of patterns in addition to the validation
indices [19]. Using visualization technique is intuitively reasonable because of the way the
human brain processes data. How to design a visualization-aided validation, thus, becomes
an intriguing and challenging task.
In this paper, building upon our multiple imputation (MI) based validation framework [17],
[24], we propose a MI-based visualization-aided validation index (called MIVOOS) to
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determine the optimal number of clusters or trajectory patterns for big incomplete
longitudinal web trial data. The validation index is defined as the weighted sum of overlap
and separation measures. By optimizing the viewing angles for the 3D Sammon-projections
and linking with MIVOOS, we obtain the optimal number of clusters. The proposed
algorithm is evaluated using real and simulated big incomplete longitudinal web trial data.
The major contributions of this paper are threefold. First, a new multiple-imputation based
overlap over separation index (MIVOOS) is proposed to identify patterns in zero-inflated
longitudinal web trial data with missing values. The proposed MIVOOS index outperforms
the existing VOS validation index in real and simulated data and unlike XB, it does not
depend on the choice of fuzzifiers. Second, a visualization aided MI based validation
framework and algorithm is generated to verify and determine the optimal number of
patterns. Third, a joint zero-inflated Poisson and autoregressive mixture model (JZARM) is
built up to simulate the mixtures of zero-inflated longitudinal web trial data.
Table 1 shows the symbols and notations used in this paper. The rest of this paper is
organized as follows: Section II discusses the proposed MI-based VOOS validation and its
algorithm. Section III illustrates the visualization aided validation framework; Section IV
presents numerical results from real and simulated big web trial data under three missing
mechanisms; and Section V concludes the paper.
 II. VALIDATION INDEX FOR WEB TRIAL ENGAGEMENT PATTERNS
The key problem in pattern recognition is to decide the optimal number of patterns. Unlike
the data structure studied in text, human brain or various networks, longitudinal behavioral
trial data, although fluctuating and complex with missing values, typically follow (non-)
linear trends. Based on our research, probability or statistical model-based (e.g., Gaussian
mixture or Bayesian), hierarchical or neural network-related clustering did not work well or
failed for this type of non-normal data, although they are popular in other study domains
[25]. Our previous research on fuzzy clustering also shows Xie and Beni (XB) index
performs consistently well in validating clusters of behavioral trial data, while the Partition
Coefficient with decreasing monotonicity (smaller is better), and Partition Entropy with
increasing monotonicity (larger is better) do not. Nevertheless, XB is dependent on the
choice of fuzzifiers and needs evaluation before selecting the optimal number of clusters
[21]. XB is widely used in fuzzy clustering validation, and expressed as,
(1)
in which uij ∈ U is the fuzzy degree of membership, xi is a vector of the observations of the
i-th case, and vk is the mean trajectory of the k-th cluster. However, our empirical results
indicate that web trial data are likely to be zero-inflated count data, in other words, it is
likely to find a pattern where patients are not or rarely engaged in trial components over
time. In this case, especially with the increase of the number of clusters k, the denominator
of XB will become zeros, leading to the infinity of XB values. Therefore, it is possible that
XB cannot point to an optimal number of clusters for zero-inflated data.
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Another recently-designed validation index in fuzzy clustering is called overlap and
separation index (VOS) [23], Using VOS on the simulated zero-inflated longitudinal web
trial data, we found no matter how the parameters and the actual number of clusters are,
VOS always pointed to three clusters. This finding indicates that the VOS may not be
suitable for zero-inflated longitudinal web trial data. Due to the disadvantages of these two
indexes, we proposed a new validation index, overlap over separation index (OOS) to find
the optimal number of clusters using MIFuzzy for such trial data. When no missing values
exist in the data, OOS can be expressed as
(2)
Definition 1: If a dataset is clustered to k clusters with a membership matrix U, let Zki and
Zkj be two fuzzy sets, the relative degree of sharing of Zki and Zkj at xi is defined as [23],
(3)
the overlap measure is defined as [23],
(4)
in which , UZj (xi), UZki (xi) and UZkj (xi) denote the fuzzy
membership degree where xi belongs to clusters Zki and Zkj, respectively.
Definition 2: If a dataset is clustered to k clusters with a membership matrix U, let Zki and
Zkj be two fuzzy sets, the separation measure is defined as
(5)
The number of clusters in the data can be inferred by minimizing the OOS index,
(6)
Although both VOS and our OOS use the concepts of overlap and separation, the differences
between the two indices are: 1) The overlap and separation measures used in OOS are not
normalized, while VOS uses normalized overlap and separation measures; 2) Unlike VOS,
OOS index uses a different separation measure with the number of clusters k as a factor.
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The real-world longitudinal web trial studies, such as QuitPrimo [26], [27], often have
incomplete data [24], which make it impossible to directly apply the OOS and other existing
validation indexes such as XB. Built upon on our MI-based validation framework [17], [24],
[28], we propose a MI-based OOS validation index (MIVOOS) to find the optimal number
of clusters for longitudinal web trial data with missing values. Briefly, multiple imputation is
conducted for an incomplete dataset and MI-based clustering is implemented for each
imputed complete data set. Specifically for MIVOOS, the MIFuzzy procedure is conducted
to obtain the fuzzy degree of cluster membership U for each k = 2, 3, …, K, then the
MIVOOS is calculated as
(7)
in which M is the number of imputations, Um is the matrix of fuzzy degree of membership of
the m-th imputed data. OOSm(k, Um) shows the OOS validation for clustering the m-th
imputed dataset into k groups. The optimal number of cluster is decided when MIVOOS
reaches its minimal value,
(8)
 III. VISUALIZATION AIDED MI-VALIDATION FOR BIG INCOMPLETE WEB
TRIAL DATA
Big data visualization, although challenging, can help us better understand the structure
(patterns) of the dataset, through a direct presentation of the trends, gaps, overlaps, or
outliers of data [29]–[35]. In this section, we designed a visualization aided algorithm to
implement the newly-proposed MIVOOS in order to decide the optimal number of clusters
in the zero-inflated longitudinal web trial data with missing values. The algorithm works as
follows: 1) Conduct MIFUZZY to obtain fuzzy membership for k = 2, 3, …, K; 2) apply the
visualization aided MIVOOS to determine the optimal number of clusters k̂; 3) output the
optimal 2-dimensional projection when k = k̂. The procedure of the proposed visualization
aided MIVOOS validation is demonstrated in Figure 1.
In this algorithm, the optimal number of clusters k̂ is first calculated by finding the minimal
MIVOOS values, then the optimal 2-dimensional projection for k̂. The linkage of MIVOOS
and our newly-improved Sammon-mapping-based visualization algorithm [19], [36], [37],
called projection-overlap measure (PO) can be calculated as
(9)
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in which γ = 0.2 is a constant value. If PO(k̂) is larger than a predefined threshold, the
optimal number of cluster decreases by 1 and the optimal 2-dimensional projections need to
be updated. The threshold of projection-overlap measure is set to be 0.1 in this work based
on our empirical evaluation and simulation studies. The algorithm of visualization aided
validation is shown in Algorithm 1.
Algorithm 1
Visualization of Identified Patterns
Require: MIVOOS
Ensure: k̂ and optimized 2D projections Xα,β
  1: Determine the number of clusters k̂ by finding the location of the minimal MIVOOS value,
  2: Get optimized 2D projections Yα,β for k̂ clusters,
  3: Calculate the PO measure for k clusters POk ̂,
  4: if POk̂ is bigger than a predefined threshold then
  5:    k̂ = k̂ − 1,
  6:    Go to step 2,
  7: end if
  8: Output number of clusters and optimized 2D projections.
To detect the optimal 2D projection, the viewing angles of 3D Sammon’s projections need
to be optimized because even if the validation index points to a minimal value, the 2D visual
graphs may not well present the number of clusters. In addition, the visualization can help
verify and determine the number of clusters because any validation index does not always
show consistent results no matter how robust it is. The Sammon’s stress can be calculated by
[36], [38]
(10)
in which  and Dij are the Euclidean distance between cases i and j in the original high-
dimensional space and the projected low-dimensional space, respectively. By Sammon’s
mapping algorithm, a high-dimensional data can be projected onto a lower dimensional
space, such as 2-dimensional (2D) plane and 3-dimensional (3D) Space. 3D scatters show
better visualization results because it has one more dimension (i.e., with more information)
than 2D scatters. However, the 3D scatters have different patterns if viewed from different
angles. Therefore, to obtain the best view of the 3D scatters and the corresponding best 2-D
view, we need to optimize the angles from which we view the scatters. There are two
parameters for the viewing angles, α and β, indicating the degrees of the horizontal rotation
and the elevation of view-point, respectively.
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To optimize the viewing angles, α and β, of the 3D scatters, we first transform the 3D
scatters to 2D projections using orthographic transformation with parameters α and β, and
then we minimize the sum of squared error (SSE), which is calculated by,
(11)
in which x ∈ ck represents all cases in the k-th cluster,  is the mean trajectory of the
projected k-th cluster. The optimal viewing angles are obtained by minimizing the SSE for
each pair of α and β,
(12)
in which α ∈ [0, 2π) and β ∈ [−π, π), Xα,β is a 2D projection of the 3D Sammon scatters
viewed from the α and β,
(13)
in which
(14)
By optimizing the view angles, we can obtain the best 2D projections of the 3D Scatters X3
using Sammon’s mapping. Additionally, the trajectory visualization is further used to verify
these longitudinal web trial data patterns. A smooth function, such as the Shape-Preserving
Piecewise Cubic Interpolation (pchip) [39], [40] can be used to display the mean trajectory
pattern which represents the trend of each cluster.
The performance of pchip is shown in Figure 2. The circled red line stands for the mean
trajectory of the first cluster in QP, smoothed by the pchip method. Compared to the spline
function, pchip is more robust, because the spline method showed negative values which are
not true for the non-negative web data as highlighted in the squares.
 IV. PERFORMANCE ANALYSIS OF VISUALIZATION-AID MIVOOS
VALIDATION
This section evaluates the proposed visualization-aided MIVOOS on real and simulated
zero-inflated longitudinal web trial data under three missing data mechanisms, missing
completely at at random (MCAR), missing at random (MAR) and missing not at random
(MNAR) [17].
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 A. BIG WEB TRIAL DATA
The real big data (N = 1320; d = 18) was collected from is a two-arm longitudinal web trial
study designed to assist in the smoking cessation of a general smoker population. The
intervention arm was engaged with three extra components which the control arm cannot
see, My Mail (MM), Online Community (OC), and Our Advice (OA). The first intervention
component, MM, describes how often smokers communicate with a tobacco treatment
specialist in a secure form. The second component, OC, measures how often the smokers are
engaged or encouraged by experts. The third main component, OA, describes how many
times smokers view messages and dialogue from peers and ex-smokers through a resource
website. As shown in Figure 3, both MI-based XB (fuzzifier = 1.1) and MIVOOS (not
depending on fuzzifier) indicate four clusters while VOS (not depending on fuzzifier) points
to two clusters. Although the optimal number of clusters k̂ could be four based on MI-XB
and MIVOOS, the visualization could help validate this result as illustrated above.
The 2D and 3D projection of QP data were further implemented according to Equation 10–
15. Figure 4(a) shows the scatters of the identified four clusters with the optimal viewing
angles, and Figure 4(b) shows its corresponding 2D projection. Figure 5(a) and 5(b) display
the 3D scatters with random viewing angles and the corresponding 2D projections,
respectively. Clearly, a random 3D projection and resulting 2D plot will mislead the
clustering results even with both MIVOOS and MI-XB pointing to 4 clusters.
To verify the optimal number of clusters, the 2D five clusters from the best view angle was
further examined for the QP data. As shown in Figure 6, Cluster 5 is likely a trivial pattern,
as it contains very few cases and is likely parsed out from Cluster 4. Figure 7 further
exhibits clear trajectory patterns (smoothed mean trajectory against individuals) representing
distinct web engagement patterns of each cluster.
 B. SIMULATION RESULTS
A joint zero inflated Poisson and Autoregressive mixture model (JZARM) is proposed to
simulate the longitudinal web trial data with missing values, given the hidden patterns, zero
inflation and time correlation in such data.
(15)
where , h is a parameter of zero-inflated Poisson model
(ZIP) and h ≥ 1, λ is the expected Poisson count, π is the probability of extra zeros. k = 1, …,
K denotes the number of clusters, i = 1, 2, …, nk, and nk denotes the number of cases in the
k-th cluster, μkit is a vector of intercepts associated with i-th case for cluster k, Φkit is the
time matrix for the k-th cluster, εkit represents white noises.
Let X be longitudinal web trial data, which consists of observed data Xobs and missing
values Xmiss, X = Xobs∪Xmiss and ϕ denotes unknown parameters. Under three missing
mechanisms, missing complete at random (MCAR), missing at random (MAR), and missing
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not at random (MNAR), we simulated incomplete web trial data using the parameters learnt
from QuitPrimo data (see Table 2 and Table 4):
1. MCAR: Simulate data assuming Xmiss does not depend on observed or
unobserved Xobs or Xmiss,
(16)
2. MAR: Simulate data assuming the missing values depend on the observed data
Xobs,
(17)
3. MNAR: Simulate data assuming missing observations relate to Xmiss or
unobserved attributes, ie., MAR assumption is violated.
Under each missing mechanism, we varied the number of cases N, dimensions d, and the
missing rate r to test our proposed algorithm. The simulation conditions are shown in Table
5. Overall, as demonstrated in Table 3, the MIVOOS always points to the correct number of
clusters, while the MI-VOS shows an incorrect number of clusters, three, under all
conditions. These results demonstrated the feasibility and robustness of the proposed
MIVOOS in zero-inflated longitudinal web trial data with missing values.
 V. CONCLUSION
Big complex data are generated from web-delivered trials. Unsupervised learning methods
are helpful in disentangling heterogeneity of treatment effects for such trials. However,
identifying valid patterns is a priority but challenging issue for these methods. This paper,
built upon our previous research on MI-based fuzzy clustering and validation, proposes a
new MI-based Visualization-aided validation index (MIVOOS) in comparison to widely-
used fuzzy clustering validation indexes, XB and VOS, to determine the optimal number of
clusters from big incomplete longitudinal web trial data with inflated zeros. Different from
XB, this index does not rely on fuzzifiers. Similar in the concepts, MIVOOS are different in
the form of computing the overlap and separation measures. Through optimizing the view
angles of 3D projections using Sammon’s mapping, the optimal 2D projection is obtained to
better visualize and can further verify the patterns identified by the MIVOOS in conjunction
with trajectory pattern visualization. Although XB identifies the same number of clusters as
MIVOOS, it needs to adjust the fuzzifiers and its formula shows the possible failure for such
zero-inflated data, although not happening on our included data. However, VOS cannot
identify the correct number of patterns for this type of web trial data in real and simulated
conditions. The findings from this project suggest that our newly-proposed MIVOOS seems
to be robust in validating big web trial data under different missing data mechanisms. Our
simulation model, called joint Zero-inflated Poisson Autoregressive Mixture (JZARM)
model, can be further utilized to simulate big web trial data to evaluate different validation
algorithms. Our future work will focus on increasing the computational efficiency of
MIFuzzy clustering and validation for big data.
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FIGURE 1.
The proposed MI-based visualization aided validation framework.
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FIGURE 2.
Smoothed mean trajectory of cluster 1 in QP.
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FIGURE 3.
Comparing MI based validation on QP. (a) MI-based XB. (b) MI-based VOS. (c) MI-based
OOS.
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FIGURE 4.
Projections of QP with the optimal view angles. (a) 3D scatters with the optimal viewing
angles. (b) 2D projections.
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FIGURE 5.
Projections of QP with random view angles. (a) 3D scatters with random viewing angles. (b)
2D projections.
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FIGURE 6.
Best 2D projections for 5 clusters of QP data.
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FIGURE 7.
Identified trajectory patterns and estimated mean and trend areas in QuitPrimo. (a) Cluster 1.
(b) Cluster 2. (c) Cluster 3. (d) Cluster 4.
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TABLE 1
Notations.
Symbols Definitions
X Longitudinal web trial data
Xobs Observations of X
Xmiss Missing values of X
N Number of observations
M Number of imputations
U Fuzzy degree of cluster membership
Zki, Zkj Two fuzzy sets
d Number of dimension
Miss Missing mechanisms
r Missing rate
k Number of clusters
k̂ Optimal number of clusters
Dij Distance between projected data
Distance between raw data
α Horizontal rotation
β Elevation of viewpoint
S Samson’s stress
μkt a vector of intercepts of cluster k at time t
Φkt Time variate matrix
εkt Serially uncorrelated innovations
λ A parameter in ZIP model
xi A vector of the observations of the i-th case
υk Centroid vector of k-th cluster
Centroid vector of projected k-th cluster
ϕ Unknown parameters of JZARM Model
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TABLE 3
Comparing new MIVOOS to MI-VOS validation under MCAR, MAR and MNAR.
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TABLE 5
Simulation conditions.
Variables Ranges
Missing mechanism (Miss) MCAR; MAR; MNAR
Number of cases (N) 1000; 2000
Number of dimensions (d) 20; 30; 40
Missing rate (r) 0.05; 0.1; 0.2; 0.4
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